QingSong Health Buys Back 1.34 Million Shares for HK$16.50 Million, Trims Free Float by 0.65%

Bulletin Express06-30 20:25

QingSong Health Corporation (HKEX: 02661) has repurchased 1.34 million ordinary shares on 30 June 2026, classifying them as treasury shares. The on-market transactions were executed within a price band of HK$12.10 to HK$13.48 per share, translating into a volume-weighted average cost of HK$12.3142 and an aggregate consideration of approximately HK$16.50 million.

Following the buyback, the company’s outstanding share count (excluding treasury shares) fell from 205.67 million to 204.33 million, a reduction of 1.34 million shares, or 0.65%. Concurrently, the treasury-share balance rose to 2.04 million shares, while the total number of issued shares remained unchanged at 206.37 million.

The transaction forms part of QingSong Health’s share repurchase mandate approved on 22 May 2026, which authorises the company to buy back up to 20.64 million shares. Cumulative repurchases under this mandate now stand at 2.04 million shares, equivalent to 0.99% of the company’s issued share capital as of the mandate date.

In accordance with Hong Kong listing regulations, the company is restricted from issuing new shares or disposing of treasury shares until 30 July 2026. QingSong Health’s board confirmed that the repurchase complied with all applicable laws, listing rules and internal authorisations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1168398645?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-30 20:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1168398645","market":"hk","top_or_hot":-1,"title":"QingSong Health Buys Back 1.34 Million Shares for HK$16.50 Million, Trims Free Float by 0.65%","media":"Bulletin Express","content":"<p>QingSong Health Corporation (HKEX: 02661) has repurchased 1.34 million ordinary shares on 30 June 2026, classifying them as treasury shares. The on-market transactions were executed within a price band of HK$12.10 to HK$13.48 per share, translating into a volume-weighted average cost of HK$12.3142 and an aggregate consideration of approximately HK$16.50 million.</p>\n<p>Following the buyback, the company’s outstanding share count (excluding treasury shares) fell from 205.67 million to 204.33 million, a reduction of 1.34 million shares, or 0.65%. Concurrently, the treasury-share balance rose to 2.04 million shares, while the total number of issued shares remained unchanged at 206.37 million.</p>\n<p>The transaction forms part of QingSong Health’s share repurchase mandate approved on 22 May 2026, which authorises the company to buy back up to 20.64 million shares. Cumulative repurchases under this mandate now stand at 2.04 million shares, equivalent to 0.99% of the company’s issued share capital as of the mandate date.</p>\n<p>In accordance with Hong Kong listing regulations, the company is restricted from issuing new shares or disposing of treasury shares until 30 July 2026. QingSong Health’s board confirmed that the repurchase complied with all applicable laws, listing rules and internal authorisations.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>QingSong Health Buys Back 1.34 Million Shares for HK$16.50 Million, Trims Free Float by 0.65%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQingSong Health Buys Back 1.34 Million Shares for HK$16.50 Million, Trims Free Float by 0.65%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-30 20:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>QingSong Health Corporation (HKEX: 02661) has repurchased 1.34 million ordinary shares on 30 June 2026, classifying them as treasury shares. The on-market transactions were executed within a price band of HK$12.10 to HK$13.48 per share, translating into a volume-weighted average cost of HK$12.3142 and an aggregate consideration of approximately HK$16.50 million.</p>\n<p>Following the buyback, the company’s outstanding share count (excluding treasury shares) fell from 205.67 million to 204.33 million, a reduction of 1.34 million shares, or 0.65%. Concurrently, the treasury-share balance rose to 2.04 million shares, while the total number of issued shares remained unchanged at 206.37 million.</p>\n<p>The transaction forms part of QingSong Health’s share repurchase mandate approved on 22 May 2026, which authorises the company to buy back up to 20.64 million shares. Cumulative repurchases under this mandate now stand at 2.04 million shares, equivalent to 0.99% of the company’s issued share capital as of the mandate date.</p>\n<p>In accordance with Hong Kong listing regulations, the company is restricted from issuing new shares or disposing of treasury shares until 30 July 2026. QingSong Health’s board confirmed that the repurchase complied with all applicable laws, listing rules and internal authorisations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02661","symbol_name":"轻松健康","start_time":0,"source_url":"","article_id":"1168398645","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1168398645","pubTimestamp":1782822313,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"QingSong Health Corporation (HKEX: 02661) has repurchased 1.34 million ordinary shares on 30 June 2026, classifying them as treasury shares. The on-market transactions were executed within a price...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02661":"轻松健康"},"translate_title":"青松健康1650万港元回购134万股自由流通量削减0.65%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02661":1},"content_text":"QingSong Health Corporation (HKEX: 02661) has repurchased 1.34 million ordinary shares on 30 June 2026, classifying them as treasury shares. The on-market transactions were executed within a price band of HK$12.10 to HK$13.48 per share, translating into a volume-weighted average cost of HK$12.3142 and an aggregate consideration of approximately HK$16.50 million.\nFollowing the buyback, the company’s outstanding share count (excluding treasury shares) fell from 205.67 million to 204.33 million, a reduction of 1.34 million shares, or 0.65%. Concurrently, the treasury-share balance rose to 2.04 million shares, while the total number of issued shares remained unchanged at 206.37 million.\nThe transaction forms part of QingSong Health’s share repurchase mandate approved on 22 May 2026, which authorises the company to buy back up to 20.64 million shares. Cumulative repurchases under this mandate now stand at 2.04 million shares, equivalent to 0.99% of the company’s issued share capital as of the mandate date.\nIn accordance with Hong Kong listing regulations, the company is restricted from issuing new shares or disposing of treasury shares until 30 July 2026. QingSong Health’s board confirmed that the repurchase complied with all applicable laws, listing rules and internal authorisations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1168398645","isCrawlerRequest":true}